share_log

Canaccord Genuity Maintains Hold on T2 Biosystems, Raises Price Target to $5

Benzinga ·  Jul 30 19:00  · Ratings

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and raises the price target from $3 to $5.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment